BR790

· Shanghai Gopherwood Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BR790, covering 2022-08-18 to 2023-02-10. Get the full timeline:

Most recent: Clinical Trial Update: BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]